Essex Bio-Technology Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Essex Bio-Technology Limited with three other
pharmaceutical manufacturers in Asia:
Panacea Biotec Ltd
sales of 5.39 billion Indian Rupees [US$82.03 million]
of which 69%
Shenzhen Weiguang Biological Products Co Ltd
(623.39 million Chinese Renmimbi [US$99.22 million]
of which 99%
was Blood Products), and
Zhejiang Wolwo Bio Pharmaceutical Co Ltd
based in China
(385.58 million Chinese Renmimbi [US$61.37 million]
of which 99%
was Pharmaceutical Manufacturing).
Essex Bio-Technology Limited reported sales of HK$899.59 million (US$114.60 million)
December of 2017.
increase of 16.0%
versus 2016, when the company's sales were HK$775.66 million.
Sales at Essex Bio-Technology Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 237%).
Sales of Sales of Pharmaceutical Products saw an increase
20.3% in 2017, from
HK$727.82 million to HK$875.20 million.
Not all segments of Essex Bio-Technology Limited experienced an increase in sales in 2017:
sales of Other Businesses fell 49.0% to HK$24.39 million.